Global Single Cell Analysis Market - Outlook to 2024: Industry Opportunities & Future Trends - ResearchAndMarkets.com

The "Single
Cell Analysis Market - Growth, Trends, and Forecast (2019 - 2024)"
report has been added to ResearchAndMarkets.com's
offering.

The Single Cell Analysis Market is expected to register a CAGR of nearly
16.5% during the forecast period, 2019-2024.

The growth of the single cell analysis market is attributed to the
technological advancements in single cell analysis products, increasing
investments in cancer research, and rising biotechnology and
biopharmaceutical industries in recent years.

Cancer is one of the major causes of deaths across the world, and there
were 8.8 million victims in 2015, accounting for nearly one in six
deaths.

The disease has witnessed significant growth in the past few decades and
is expected to rise rapidly over the forecast period. According to the
World Health Organization (WHO), 10.9 million new cases of cancer were
identified in 2002, which grew substantially over the next decade to
approximately 14.1 million in 2012. An estimated 30% growth was observed
over the decade. Moreover, WHO estimated the growth to increasing to 70%
over the next two decades, worldwide.

Circulating tumor cells are gaining increasing clinical attention since
they are likely to enable the monitoring of cancer progression and
adjustment of treatment. In such cases, single-cell sequencing analysis
has found its application in search of better diagnostic and prognostic
biomarkers.

In recent years, multiple technologies for enrichment, isolation, as
well as molecular and functional analysis of circulating tumor cells
have been developed, such as single cell analysis. In 2014, the Clinical
Research Infrastructure Initiative brought together several funding
organizations, such as the Welcome Trust and Cancer Research UK, in
partnership, led by the Medical Research Council (MRC), in order to
invest over GBP 230 million for single-cell genomics for cancer studies.

In clinical diagnostics, single cell analysis is expected to standardize
and automate workflows with valuable information for real-time
monitoring of cancer and eventually new therapeutic strategies for the
benefit of patients. This is expected to lead to more efficient and
better analysis. Therefore, increasing investments in cancer research is
considered as one of the major driving factors for the market over the
forecast period.

Key Market Trends

Immunology Research Application is Expected to Grow with High CAGR
During the Forecast Period

The cancer segment held the maximum share in 2018, owing to a high
prevalence of cancer, initiatives for early detection, and increasing
awareness regarding commercially available cancer diagnostics.

Immunology studies to aid in the early detection of therapeutic
complications and increases the efficiency of the treatment.
Furthermore, invasion of metabolic activities of single cells is
increasing the adoption of its analytical tools, thus propelling the
growth of immunology research segment.

North America Region Holds the Largest Market Share of Single Cell
Analysis Market Currently and is Believed to Follow the Same Trend over
the Forecast Period

The large share of the North American single cell analysis market is
attributed to factors, such as increasing collaborations among prominent
players, technological advancements, and expanding biotechnology and
pharmaceutical industries. In recent years, several government
initiatives have been launched that are supplementing the growth of the
single cell analysis market in the region. For example, in 2015, the
Precision Medicine Initiative was introduced to revolutionize the
treatment of chronic diseases, including cancer.

The Asia-Pacific market is expected to witness the fastest growth during
the forecast period, which is attributed to numerous government
initiatives undertaken to improve healthcare infrastructure,
availability of skilled professionals to operate advanced analytical
instruments, and rising healthcare expenditure.

Competitive Landscape

The single cell analysis market consists of several major players. The
companies are implementing certain strategic initiatives, such as
mergers, new product launches, acquisitions, and partnerships that help
them in strengthening their market position. For instance, Illumina Inc.
and Bio-Rad Laboratories Inc. entered into a strategic collaboration in
2016, to co-develop comprehensive solution for single cell genomics

Key Topics Covered

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Technological Advancements in Single Cell Analysis Products

4.2.2 Increasing Investments in Cancer Research

4.2.3 Rising Biotechnology and Biopharmaceutical Industries

4.3 Market Restraints

4.3.1 High Cost of Single Cell Analysis Instruments

4.4 Porter's Five Forces Analysis

5 MARKET SEGMENTATION

5.1 By Cell Type

5.1.1 Human

5.1.2 Animal

5.1.3 Microbial

5.2 By Technique

5.2.1 Flow Cytometry

5.2.2 Next generation Sequencing

5.2.3 Polymerase Chain Reaction (PCR)

5.2.4 Microscopy

5.2.5 Mass Spectrometry

5.2.6 Other Techniques

5.3 By Application

5.3.1 Research Applications

5.3.1.1 Cancer Research

5.3.1.2 Immunology Research

5.3.1.3 Neurology Research

5.3.1.4 Stem Cell Research

5.3.1.5 Other Research Applications

5.3.2 Medical Application

5.3.2.1 Non-invasive Prenatal Diagnosis

5.3.2.2 In Vitro Fertilization

5.3.2.3 Circulating Tumor Cell Detection

5.4 By End User

5.4.1 Academic and Research Laboratories

5.4.2 Biotechnology and Pharmaceutical Companies

5.4.3 Hospital and Diagnostic Laboratories

5.5 Geography

5.5.1 North America

5.5.2 Europe

5.5.3 Asia-Pacific

5.5.4 Middle East & Africa

5.5.5 South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Agilent Technologies

6.1.2 Beckman Coulter Inc.

6.1.3 Becton, Dickinson, and Company

6.1.4 Bio-Rad Laboratories Inc.

6.1.5 Fluidigm Corporation

6.1.6 GE Healthcare

6.1.7 Illumina Inc.

6.1.8 Merck KGaA

6.1.9 Qiagen N.V.

6.1.10 Thermo Fisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/research/gm24qv/global_single?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190326005925/en/